Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05432817 · ClinicalTrials.gov registry record · NA
PTSD Treatment for Incarcerated Men and Women: WPP
A NA study of PTSD, sponsored by University of Wisconsin, Madison.
- Active
- Registry status
- NA
- Development phase
- 117
- Enrollment target
- 1
- Study location
NCT05432817: Active NA study of PTSD, sponsored by University of Wisconsin, Madison.
NCT05432817 is a NA study of PTSD that is active but no longer recruiting, run by University of Wisconsin, Madison. The registered enrollment target is 117 participants, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05432817, a NA study of PTSD, is active but no longer recruiting, sponsored by University of Wisconsin, Madison.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 117 participants
- Enrollment target
- 1
- Study location
Study Summary
Study examining the psychological response to group Cognitive Processing Therapy (CPT) in incarcerated men and women with Post-traumatic stress disorder (PTSD). The study will be conducted in male and female incarcerated populations and will include 2 groups of individuals for both CPT and waitlist control in both populations (180 participants total).
Primary Outcome
PTSD symptom severity is measured by PCL-5 questionnaire (scores from 0, no symptoms, to 80, high severity); primary measure of intervention efficacy
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Processing Therapy
Study Locations (1)
Wisconsin
- Psychiatric Institute and Clinic - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2024-01-04 |
| Est. Completion | 2026-04 |
| Phase | NA |
What the registry record for NCT05432817 still lists
NCT05432817 is an interventional study that assigns participants to a tested intervention. The registered 117 participants enrollment target is mid-sized for trials with a published cap, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (61% lower).
The record links to 1 condition, with PTSD appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Processing Therapy is the first listed.
NCT05432817 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05432817 about?
NCT05432817 is a clinical study titled "PTSD Treatment for Incarcerated Men and Women: WPP". Study examining the psychological response to group Cognitive Processing Therapy (CPT) in incarcerated men and women with Post-traumatic stress disorder (PTSD). The study will be conducted in male and female incarcerated populations and will include 2 groups of individuals for both CPT and waitlist ...
What is the current status of trial NCT05432817?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 117 participants. The study started on 2024-01-04. Estimated completion is 2026-04.
What conditions does trial NCT05432817 study?
This clinical trial studies the following conditions: PTSD.
What interventions are being tested in trial NCT05432817?
The interventions under investigation include: Cognitive Processing Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05432817?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05432817 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05432817's enrollment target sits among peer trials
117 58th of 154 higher than 97 of 154 other PTSD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
REstoring Mental Health Through COmmUnity-based Psychological Services in New York City
RECRUITING · NA
-
Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building
RECRUITING · NA
-
Project Safe Guard-Trauma
RECRUITING · NA
-
Neuromodulation of the Fear Extinction Circuit Using Temporally and Anatomically Specific TMS in Humans
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03539822 · 117 participants · Phase 1
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
- NCT03786692 · 117 participants · Phase 2
Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC
- NCT04479696 · 117 participants · NA
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
- NCT04940585 · 117 participants · NA
ROSE in Sunset Park
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI